文献速递心律失常

多基因风险评分预测钠通道阻滞剂心脏电反应及Brugada综合征

Predicting cardiac electrical response to sodium-channel blockade and Brugada syndrome using polygenic risk scores.
PubMed 文献 · Eur Heart J · 2019-01-01

AIMS: Sodium-channel blockers (SCBs) are associated with arrhythmia, but variability of cardiac electrical response remains unexplained. We sought to identify predictors of ajmaline-induced PR and QRS changes and Type I Brugada syndrome (BrS) electrocardiogram (ECG).…

要点

  • PRSPR、基线PR和女性与更显著的PR斜率相关,PRSQRS和年龄与QRS斜率正相关。
  • PRSBrS、基线QRS时限、基线II/III型Brugada心电图和家族史独立预测I型Brugada心电图。
  • 预测模型乐观校正C统计量0.74,提示临床相关准确性。

核心结论

  • 遗传因素首次被证明 underlie 钠通道阻滞剂心脏电反应变异。
  • PRSBrS、家族史和基线心电图可临床相关准确地预测药物诱导的I型Brugada心电图。

研究设计与样本

  • 研究纳入1368例因疑似Brugada综合征接受阿义马林输注的患者。
  • 计算PR间期(PRSPR)、QRS时限(PRSQRS)和Brugada综合征(PRSBrS)的多基因风险评分,使用回归分析识别预测因子。
  • 通过自举法推导和验证预测模型。

主要发现

  • PRSPR、基线PR和女性与更显著的PR斜率相关(P < 0.01)。
  • PRSQRS和年龄与QRS斜率正相关(P < 0.01)。
  • PRSBrS、基线QRS时限、基线II或III型Brugada心电图和Brugada综合征家族史独立与I型Brugada心电图发生相关。
  • 预测模型乐观校正C统计量为0.74。

关键数值与推荐

  • PRSPR、基线PR和女性与PR斜率相关(P < 0.01)。
  • PRSQRS和年龄与QRS斜率正相关(P < 0.01)。
  • 预测I型Brugada心电图的乐观校正C统计量为0.74。

临床怎么用

  • PRSBrS联合家族史和基线心电图可用于预测药物诱导的I型Brugada心电图。
  • 研究提示PRS可能用于Brugada综合征诊断,并识别钠通道阻滞剂毒性风险患者(需人群研究确认)。

局限性

  • 原文未报告

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIMS: Sodium-channel blockers (SCBs) are associated with arrhythmia, but variability of cardiac electrical response remains unexplained. We sought to identify predictors of ajmaline-induced PR and QRS changes and Type I Brugada syndrome (BrS) electrocardiogram (ECG). METHODS AND RESULTS: In 1368 patients that underwent ajmaline infusion for suspected BrS, we performed measurements of 26 721 ECGs, dose-response mixed modelling and genotyping. We calculated polygenic risk scores (PRS) for PR interval (PRSPR), QRS duration (PRSQRS), and Brugada syndrome (PRSBrS) derived from published genome-wide association studies and used regression analysis to identify predictors of ajmaline dose related PR change (slope) and QRS slope. We derived and validated using bootstrapping a predictive model for ajmaline-induced Type I BrS ECG. Higher PRSPR, baseline PR, and female sex are associated with more pronounced PR slope, while PRSQRS and age are positively associated with QRS slope (P < 0.01 for all). PRSBrS, baseline QRS duration, presence of Type II or III BrS ECG at baseline, and family history of BrS are independently associated with the occurrence of a Type I BrS ECG, with good predictive accuracy (optimism-corrected C-statistic 0.74). CONCLUSION: We show for the first time that genetic factors underlie the variability of cardiac electrical response to SCB. PRSBrS, family history, and a baseline ECG can predict the development of a diagnostic drug-induced Type I BrS ECG with clinically relevant accuracy. These findings could lead to the use of PRS in the diagnosis of BrS and, if confirmed in population studies, to identify patients at risk for toxicity when given SCB.

来源:Eur Heart J,查看原文。版权归原作者所有。

引用

  1. Tadros R, Tan HL, El Mathari S, et al. Predicting cardiac electrical response to sodium-channel blockade and Brugada syndrome using polygenic risk scores. Eur Heart J. 2019. PMID: 31504448. doi:10.1093/eurheartj/ehz435

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。